Amma: your trial nurse

Your digital trial nurse

Published by: Neuroventis
Downloads
Revenue

Description

The Amma app is a revolutionary tool designed to empower individuals living with epilepsy to actively participate in clinical trials and contribute to advancements in epilepsy research. Developed with the collaboration of leading neurologists, researchers, and individuals with epilepsy, this app offers a comprehensive platform that seamlessly connects patients with ongoing clinical trials, provides valuable resources, and enhances communication between patients and healthcare providers.
The Amma app aims to revolutionize the way individuals with epilepsy engage with clinical research, fostering collaboration between patients, researchers, and healthcare providers to accelerate the development of innovative treatments and ultimately improve the lives of those affected by epilepsy.
Hide Show More...

Screenshots

Amma FAQ

  • Is Amma free?

    Yes, Amma is completely free and it doesn't have any in-app purchases or subscriptions.

  • Is Amma legit?

    Not enough reviews to make a reliable assessment. The app needs more user feedback.

    Thanks for the vote

  • How much does Amma cost?

    Amma is free.

  • What is Amma revenue?

    To get estimated revenue of Amma app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.

User Rating
App is not rated in Belgium yet.
Ratings History

Amma Reviews

No Reviews in Belgium
App doesn't have any reviews in Belgium yet.

Store Rankings

Ranking History
App Ranking History not available yet
Category Rankings
App is not ranked yet

Amma Installs

Last 30 days

Amma Revenue

Last 30 days

Amma Revenue and Downloads

Gain valuable insights into Amma performance with our analytics.
Sign up now to access downloads, revenue, and more.

App Info

Category
Medical
Publisher
Neuroventis
Languages
English
Recent release
1.0.0 (1 month ago )
Released on
Sep 20, 2024 (3 months ago )
Last Updated
1 week ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.